KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Operating Income: 2017-2024

Historic Operating Income for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$1.4 billion.

  • BioNTech SE's Operating Income fell 52.16% to $29.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.1 million, marking a year-over-year increase of 81.61%. This contributed to the annual value of -$1.4 billion for FY2024, which is 289.07% down from last year.
  • According to the latest figures from FY2024, BioNTech SE's Operating Income is -$1.4 billion, which was down 289.07% from $742.8 million recorded in FY2023.
  • In the past 5 years, BioNTech SE's Operating Income registered a high of $17.5 billion during FY2021, and its lowest value of -$1.4 billion during FY2024.
  • Moreover, its 3-year median value for Operating Income was $742.8 million (2023), whereas its average is $4.1 billion.
  • Per our database at Business Quant, BioNTech SE's Operating Income surged by 17,896.61% in 2021 and then slumped by 289.07% in 2024.
  • Over the past 5 years, BioNTech SE's Operating Income (Yearly) stood at -$98.2 million in 2020, then soared by 17,896.61% to $17.5 billion in 2021, then fell by 26.23% to $12.9 billion in 2022, then tumbled by 94.24% to $742.8 million in 2023, then tumbled by 289.07% to -$1.4 billion in 2024.